Search research articles
Contact Us
Filters
Showing results (611-620 of 692) with videos related to
Page
of 70
Sort By:
Cell Death & Disease
|
May 6, 2022
Stage IV colon cancer patients without DENND2D expression benefit more from neoadjuvant chemotherapy
Wen-Juan Ma, Yukun Chen, Jian-Hong Peng, et al.
JHEP Reports : Innovation in Hepatology
|
February 12, 2026
Pathological response ≥90% predicts survival in HCC treated with neoadjuvant loco-regional therapies: A retrospective cohort study
Li-Ying Ou-Yang, Yi-Xiang Gan, Chao Zhang, et al.
Frontiers in Immunology
|
August 4, 2025
Quality-of-life scale machine learning approach to predict immunotherapy response in patients with advanced non-small cell lung cancer
Juanyan Shen, Junliang Ma, Shaolin Chen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 23, 2010
Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury
Shuang-Shuang Dai, Yuan-Guo Zhou, Wei Li, et al.
Cellular and Molecular Life Sciences : CMLS
|
February 22, 2025
NR4A1 deficiency promotes carotid plaque vulnerability by activating integrated stress response via targeting Bcat1
Long Chen, Yiping Shi, Danrui Xiao, et al.
Mitochondrial DNA. Part B, Resources
|
February 25, 2021
Characterization of the complete chloroplast genome of 'Yunning No.1' lemon (<i>Citrus limon</i>)
Shao-Hua Wang, Guang-Zhou Deng, Jun-Yan Gao, et al.
Cancer Medicine
|
March 19, 2019
Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma
Yan-Ji Jiang, Jian-Hong Zhong, Zi-Han Zhou, et al.
American Journal of Cancer Research
|
June 9, 2020
Preventive effect of celecoxib in sorafenib-related hand-foot syndrome in hepatocellular carcinoma patients, a single-center, open-label, randomized, controlled clinical phase III trial
Jian-Cong Chen, Jun-Cheng Wang, Yang-Xun Pan, et al.
Bioengineered
|
August 9, 2021
Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues
Wei-Jian Huang, Wei-Ying He, Jian-Di Li, et al.
Frontiers in Oncology
|
October 1, 2025
A synthetic cohort analysis of postoperative management of primary cardiac angiosarcoma and a case report
Ying Cai, Hang Yang, Dan Yuan, et al.
Page
of 70
Search research articles
Search
Showing results (611-620 of 692) with videos related to
Sort By:
Page
of 70
Cell Death & Disease
|
May 6, 2022
Stage IV colon cancer patients without DENND2D expression benefit more from neoadjuvant chemotherapy
Wen-Juan Ma, Yukun Chen, Jian-Hong Peng, et al.
JHEP Reports : Innovation in Hepatology
|
February 12, 2026
Pathological response ≥90% predicts survival in HCC treated with neoadjuvant loco-regional therapies: A retrospective cohort study
Li-Ying Ou-Yang, Yi-Xiang Gan, Chao Zhang, et al.
Frontiers in Immunology
|
August 4, 2025
Quality-of-life scale machine learning approach to predict immunotherapy response in patients with advanced non-small cell lung cancer
Juanyan Shen, Junliang Ma, Shaolin Chen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 23, 2010
Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury
Shuang-Shuang Dai, Yuan-Guo Zhou, Wei Li, et al.
Cellular and Molecular Life Sciences : CMLS
|
February 22, 2025
NR4A1 deficiency promotes carotid plaque vulnerability by activating integrated stress response via targeting Bcat1
Long Chen, Yiping Shi, Danrui Xiao, et al.
Mitochondrial DNA. Part B, Resources
|
February 25, 2021
Characterization of the complete chloroplast genome of 'Yunning No.1' lemon (<i>Citrus limon</i>)
Shao-Hua Wang, Guang-Zhou Deng, Jun-Yan Gao, et al.
Cancer Medicine
|
March 19, 2019
Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma
Yan-Ji Jiang, Jian-Hong Zhong, Zi-Han Zhou, et al.
American Journal of Cancer Research
|
June 9, 2020
Preventive effect of celecoxib in sorafenib-related hand-foot syndrome in hepatocellular carcinoma patients, a single-center, open-label, randomized, controlled clinical phase III trial
Jian-Cong Chen, Jun-Cheng Wang, Yang-Xun Pan, et al.
Bioengineered
|
August 9, 2021
Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues
Wei-Jian Huang, Wei-Ying He, Jian-Di Li, et al.
Frontiers in Oncology
|
October 1, 2025
A synthetic cohort analysis of postoperative management of primary cardiac angiosarcoma and a case report
Ying Cai, Hang Yang, Dan Yuan, et al.
Page
of 70